IPO - Profile

Summary

Offer Price Offer Size 3-Year Outlook Volatility First Day Turnover
$10.00 3,520,000 Positive High 109.92%

Offering Team

  • Legal counsel
  • Alston & Bird LLP
  • Auditors
  • KPMG LLP

Deal Highlights

Journey Medical Corporation is a commercial-stage pharmaceutical company founded in October 2014 that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Our current portfolio includes five branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the U.S. We are managed by experienced life science executives with a track record of creating value for their stakeholders and bringing novel medicines to the market, enabling patients to experience increased quality of life, and enabling physicians and other licensed medical professionals to provide better care for their patients. We aim to acquire rights to future products by licensing or otherwise acquiring an ownership interest in, funding the research and development of, and eventually commercializing, the products through our field sales organization. Since inception, we have made significant investments to build out our commercial product portfolios, which we believe, coupled with our experienced dermatology sales leadership team and our recently expanded field sales force, will position our business for growth.

Deal Tracker

IPO Dates

Filing 10 Nov, 2021

Offer 12 Nov, 2021

Look Ahead

Lock Up Expiry May 12, 2022

IPO Terms

Offer Price $10.00
Offer Size 3M

Market Sentiments

Stock Price